Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.
2.
3.

Research on complementary and alternative medicine using randomized controlled trials.

Harlan WR Jr.

J Altern Complement Med. 2001;7 Suppl 1:S45-52. Review.

PMID:
11822635
4.
5.

Blending the boundaries: steps toward an integration of complementary and alternative medicine into mainstream practice.

Giordano J, Boatwright D, Stapleton S, Huff L.

J Altern Complement Med. 2002 Dec;8(6):897-906. Review.

PMID:
12614540
6.

The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.

Kantor M.

J Am Coll Radiol. 2009 Apr;6(4):254-62. doi: 10.1016/j.jacr.2008.09.012.

PMID:
19327658
7.

Complementary and alternative therapeutics: rigorous research is needed to support claims.

Kinsel JF, Straus SE.

Annu Rev Pharmacol Toxicol. 2003;43:463-84. Epub 2002 Jan 10. Review.

PMID:
12540748
8.
9.

Use of complementary medicine by adult patients participating in cancer clinical trials.

Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J.

Oncol Nurs Forum. 2000 May;27(4):623-30.

PMID:
10833691
10.

Survey of complementary and alternative medicine practitioners regarding cancer management and research.

Colleen Lee CD, Zia F, Olaku O, Michie J, White JD.

J Soc Integr Oncol. 2009 Winter;7(1):26-34.

11.
12.

Complementary and alternative medicine. Considering the alternatives.

Weber DO.

Physician Exec. 1998 Nov-Dec;24(6):6-14.

PMID:
10351720
13.
14.

[A research roadmap for complementary and alternative medicine - what we need to know by 2020].

Fischer F, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B.

Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.

PMID:
24851850
15.

Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies.

Sparber A, Wootton JC.

J Altern Complement Med. 2001 Jun;7(3):281-7. Review.

PMID:
11439851
16.

NCCAM support for the Cochrane Collaboration CAM Field.

Manheimer E, Berman B.

Complement Ther Med. 2003 Dec;11(4):268-71.

PMID:
15022665
17.

Complementary and alternative medicine: opportunities and challenges for cancer management and research.

Richardson MA, Straus SE.

Semin Oncol. 2002 Dec;29(6):531-45. Review.

PMID:
12516036
18.

Rationales for CAM Education in Health Professions Training Programs.

Gaylord SA, Mann JD.

Acad Med. 2007 Oct;82(10):927-33. Review.

PMID:
17895650
19.

State of the center, CAM use in cancer patients, and initiatives with the FDA are topics of 14th NACCAM meeting.

Le Tourneau M.

Altern Ther Health Med. 2003 Jul-Aug;9(4):18. No abstract available.

PMID:
12868248
20.

[Development of traditional Chinese medicine in United States].

Tian XM.

Beijing Da Xue Xue Bao. 2012 Oct 18;44(5):715-9. Chinese.

Supplemental Content

Support Center